Hsa-miR-665, a microRNA molecule, has emerged as a promising biomarker with significant potential in the realm of cancer prognosis. This review explores the landscape of Hsa-miR-665 and its role as a prognostic indicator in various cancer types. By examining the latest research findings and its implications, this review underscores the significance of Hsa-miR-665 as a biomarker in predicting disease outcomes, aiding clinical decisionmaking and advancing personalized cancer care.
HTML PDFShare this article
Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report
